Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Signal Transduction and Targeted Therapy|March 24, 2021
The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signalingYanyan Zhang, Baohua Li, Qiang Bai, et al.
Nano Letters|August 6, 2025
Creating Extrinsic Self-Trapped Excitons by Isoelectronic Doping for Lead-Free High-Efficiency Light Emission and High-Performance X-ray ScintillatorsTao Chen, Feng Lin, Wenjun Tang, et al.
Medcomm|March 14, 2022
Differential expression of inhibitory receptor NKG2A distinguishes disease-specific exhausted CD8+ T cellsXiangyu Chen, Yao Lin, Shuai Yue, et al.
ACS Nano|May 9, 2025
Enhanced Interfacial Exciton Transport in Mixed 2D/3D Perovskites Approaching Bulk 3D CounterpartsYin Liang, Xiaoyue Gao, Chun Li, et al.
Signal Transduction and Targeted Therapy|September 4, 2020
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19Xiangyu Chen, Zhiwei Pan, Shuai Yue, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 21, 2022
Integration of Highly Luminescent Lead Halide Perovskite Nanocrystals on Transparent Lead Halide Nanowire Waveguides through Morphological Transformation and Spontaneous Growth in WaterTao Chen, Chong Wang, Xinxin Xing, et al.
Molecular Therapy. Oncology|April 30, 2026
Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4+ T cells to inhibit systemic microbial infectionShuai Yue, Junjian He, Shusen Ye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2022
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical TrialYao Lin, Shuai Yue, Yang Yang, et al.
Frontiers in Immunology|October 11, 2021
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal AntibodyShuai Yue, Zhirong Li, Yao Lin, et al.
Nature Cancer|April 12, 2024
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapyXiangyu Chen, Jing Zhao, Shuai Yue, et al.
Pageof 10